Diabetes genetics ,biomarker and epidemiology

Diabetes mellitus patients are more likely to develop coronavirus disease 2019 (COVID-19), which is caused by infection with the severe acute respiratory syndrome coronavirus 2. COVID-19 may increase the risk of hyperglycemia in infected individuals. When combined with other risk factors, hyperglycemia may modulate immunological and inflammatory responses, predisposing individuals to severe COVID-19 and potentially fatal outcomes. Patients with diabetes should be aware that COVID-19 can raise blood glucose levels, so they should follow clinical guidelines for diabetes management more closely during the treatment period as:

  • Controlling glucose levels in pandemic
  • Inflammation and diabetes
  • Immunology and diabetes
  • Diabetes after COVID-19 positive

    Related Conference of Diabetes genetics ,biomarker and epidemiology

    September 09-10, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    September 09-10, 2024

    4th European Endocrinology and Diabetes Congress

    Paris, France
    September 25-26, 2024

    5th World Summit on Diabetes Expo

    Rome, Italy
    October 14-15, 2024

    3rd International Summit on Hormonal Disorders

    Madrid, Spain
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands

    Diabetes genetics ,biomarker and epidemiology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in